Evidence map›Paper›PMID 28760742›Full record

Observational studyDiabetes care2017

All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes.

Michelle R Lent, Peter N Benotti, Tooraj Mirshahi, Glenn S Gerhard, William E Strodel, Anthony T Petrick, Jon D Gabrielsen, David D Rolston, Christopher D Still, Annemarie G Hirsch and 4 more

Abstract readObservational Study
In one paragraph

Observational study in Diabetes care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Drug poisonings following bariatric surgery: Case series report.British journal of clinical pharmacology · 2026
    Article
  7. Article
  8. Metabolic surgery versus usual care effects on mortality among patients with obesity and type 2 diabetes: A systematic review and meta-analysis.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
    Review
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Michelle R LentObesity Institute, Geisinger Clinic, Danville, PA mrlent1@geisinger.edu.ORCID 0000-0001-7892-1879
Peter N BenottiObesity Institute, Geisinger Clinic, Danville, PA.
Tooraj MirshahiDepartment of Molecular and Functional Genomics, Geisinger Health System, Danville, PA.
Glenn S GerhardLewis Katz School of Medicine, Temple University, Philadelphia, PA.
William E StrodelDepartment of Surgery, Geisinger Clinic, Danville, PA.
Anthony T PetrickDepartment of Surgery, Geisinger Clinic, Danville, PA.
Jon D GabrielsenDepartment of Surgery, Geisinger Clinic, Danville, PA.
David D RolstonDepartment of Internal Medicine, Geisinger Clinic, Danville, PA.
Christopher D StillObesity Institute, Geisinger Clinic, Danville, PA.
Annemarie G HirschDepartment of Epidemiology and Health Services Research, Geisinger Health System, Danville, PA.ORCID 0000-0001-7699-2171
Fahad ZubairCenter for Nutrition and Weight Management, Geisinger Clinic, Danville, PA.
Adam CookObesity Institute, Geisinger Clinic, Danville, PA.
David J CareyDepartment of Molecular and Functional Genomics, Geisinger Health System, Danville, PA.
G Craig WoodObesity Institute, Geisinger Clinic, Danville, PA.

Funding

Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D, TAYLOR, SIMEON I. · 2005 to 2019
$17.3M
NIDDK NIH HHS P30 DK072488
6 · The paper itself

Abstract

objectiveThis study assessed all-cause and specific-cause mortality after Roux-en-Y gastric bypass (RYGB) and in matched control subjects, stratified by diabetes status. RESEARCH DESIGN AND

methodsRYGB patients were matched by age, BMI, sex, and diabetes status at time of surgery to nonsurgical control subjects using data from the electronic health record. Kaplan-Meier curves and Cox regression were used to assess differences in all-cause and specific-cause mortality between RYGB patients and control subjects with and without diabetes.

resultsOf the 3,242 eligible RYGB patients enrolled from January 2004 to December 2015, control subjects were identified for 2,428 (

conclusionsAll-cause mortality benefits of RYGB are driven predominantly by patients with diabetes at the time of surgery. RYGB patients with diabetes were less likely to die of cardiovascular diseases, diabetes, and respiratory conditions than their counterparts without RYGB.

Indexed as

AdultBody Mass IndexDiabetes MellitusFemaleFollow-Up StudiesGastric BypassHumansLongitudinal StudiesMaleMiddle AgedMortalityPostoperative PeriodProportional Hazards ModelsRetrospective StudiesRisk FactorsWeight Loss

Identifiers

PMID28760742
PMCPMC5606311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.